156 related articles for article (PubMed ID: 33364197)
21. Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response.
Lee HC; Ko H; Seol H; Noh DY; Han W; Kim TY; Im SA; Park IA
J Breast Cancer; 2013 Dec; 16(4):395-403. PubMed ID: 24454461
[TBL] [Abstract][Full Text] [Related]
22. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
[TBL] [Abstract][Full Text] [Related]
23. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Hylton NM; Blume JD; Bernreuter WK; Pisano ED; Rosen MA; Morris EA; Weatherall PT; Lehman CD; Newstead GM; Polin S; Marques HS; Esserman LJ; Schnall MD;
Radiology; 2012 Jun; 263(3):663-72. PubMed ID: 22623692
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study.
Skarping I; Förnvik D; Heide-Jørgensen U; Rydén L; Zackrisson S; Borgquist S
Acta Oncol; 2020 Dec; 59(12):1528-1537. PubMed ID: 33063567
[TBL] [Abstract][Full Text] [Related]
25. Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy.
Geng SK; Fu SM; Ma SH; Fu YP; Zhang HW
BMC Cancer; 2021 Jan; 21(1):68. PubMed ID: 33446143
[TBL] [Abstract][Full Text] [Related]
26. Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer.
Fan M; Chen H; You C; Liu L; Gu Y; Peng W; Gao X; Li L
Front Mol Biosci; 2021; 8():622219. PubMed ID: 33869279
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI.
Evans A; Whelehan P; Thompson A; Purdie C; Jordan L; Macaskill J; Waugh S; Fuller-Pace F; Brauer K; Vinnicombe S
Ultraschall Med; 2018 Aug; 39(4):422-431. PubMed ID: 28934812
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
[TBL] [Abstract][Full Text] [Related]
29. A Practical Predictive Model Based on Ultrasound Imaging and Clinical Indices for Estimation of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Ye P; Duan H; Zhao Z; Fang S
Cancer Manag Res; 2021; 13():7783-7793. PubMed ID: 34675673
[TBL] [Abstract][Full Text] [Related]
30. Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer.
Liu B; Su F; Li Y; Qi X; Liu X; Liang W; You K; Zhang Y; Zhang J
Biomed Pharmacother; 2017 Apr; 88():911-917. PubMed ID: 28178621
[TBL] [Abstract][Full Text] [Related]
31. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
[TBL] [Abstract][Full Text] [Related]
32. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
[TBL] [Abstract][Full Text] [Related]
33. EarlyR signature predicts response to neoadjuvant chemotherapy in breast cancer.
Buechler SA; Gökmen-Polar Y; Badve SS
Breast; 2019 Feb; 43():74-80. PubMed ID: 30502641
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.
Huang Y; Chen W; Zhang X; He S; Shao N; Shi H; Lin Z; Wu X; Li T; Lin H; Lin Y
Front Bioeng Biotechnol; 2021; 9():662749. PubMed ID: 34295877
[No Abstract] [Full Text] [Related]
35. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.
Chintamani ; Singh JP; Mittal MK; Saxena S; Bansal A; Bhatia A; Kulshreshtha P
World J Surg Oncol; 2005 Sep; 3():61. PubMed ID: 16164742
[TBL] [Abstract][Full Text] [Related]
36. TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer.
Wang K; Chai J; Xu J; Wei J; Li P; Liu Y; Ma J; Xu T; Zhao D; Yu K; Fan L; Yan Q; Guo S; Li M; Wang Z
Pathol Res Pract; 2021 Oct; 226():153603. PubMed ID: 34500374
[TBL] [Abstract][Full Text] [Related]
37. Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies.
Desa DE; Bhanote M; Hill RL; Majeski JB; Buscaglia B; D'Aguiar M; Strawderman R; Hicks DG; Turner BM; Brown EB
J Biomed Opt; 2019 Aug; 24(8):1-9. PubMed ID: 31456385
[TBL] [Abstract][Full Text] [Related]
38. Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma.
Xie M; Zhang X; Jia Z; Ren Y; Wang W
Oncol Lett; 2014 Oct; 8(4):1652-1656. PubMed ID: 25202385
[TBL] [Abstract][Full Text] [Related]
39. ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
Veys I; Pop CF; Barbieux R; Moreau M; Noterman D; De Neubourg F; Nogaret JM; Liberale G; Larsimont D; Bourgeois P
PLoS One; 2018; 13(5):e0197857. PubMed ID: 29799849
[TBL] [Abstract][Full Text] [Related]
40. The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy.
Xie Z; Zhen T; Lin Y; Shao N; Kuang X
Gland Surg; 2022 Nov; 11(11):1808-1816. PubMed ID: 36518803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
